Bryce Point Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,782	Closed	-$837K	–	238
2025 Q1	$837K	Buy	+6,782	New	+$837K	0.63%	76